Peripheral Vascular Devices Market Size, Share & Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Peripheral Vascular Stents, PTA Balloon Catheters, and 17 more
- Year: 2023
- Scope: 10 Years
- Region: United States
- Pages: 756
- Published Date: 2023-02-14
- Type: MedSuite
Overall, the U.S. peripheral vascular device market was valued at $8 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.4% to reach $10.9 billion.
The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.
Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Peripheral Vascular Procedure Volumes
- Market Forecasts Until 2029, and Historical Data to 2019
- Market Drivers & Limiters for Each Peripheral Vascular Device market
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
U.S. PERIPHERAL VASCULAR DEVICE PROCEDURE NUMBERS
Peripheral vascular procedures include plain-old balloon angioplasty (POBA), stenting, drug-coated balloon (DCB), atherectomy, intravascular lithotripsy, CTO crossing, surgical graft, stent graft, embolic protection, peripheral thrombus management, inferior vena cava filter placement, carotid intervention, vascular closure, transcatheter embolization and peripheral IVUS procedures. Many peripheral vascular procedures are performed using a vascular closure device. Intravascular lithotripsy and embolic protection devices are used in a small sub-set of peripheral vascular procedures.
U.S. PERIPHERAL VASCULAR DEVICE MARKET TRENDS
One of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital. As more OBLs continue to be developed, and more procedures continue to be shifted towards this setting, pricing pressure is expected on PTA balloons, stents, atherectomy devices and associated products for performing routine procedures.
U.S. PERIPHERAL VASCULAR DEVICE MARKET SHARE INSIGHTS
Within the U.S. vascular access market there are 3 top market share competitors – Medtronic, W.L. Gore, and Boston Scientific.
Medtronic was the leading competitor in the total peripheral vascular devices market in 2022. The company derives the majority of its revenue from its strong showing in the high value stent graft, DCB and atherectomy market segments. Medtronic led the U.S. DCB market in 2022. The addition of a DCB to Medtronic’s portfolio has buoyed the company’s share of adjacent market segments, including bare-metal stents, standard PTA balloons and more. The company’s broad market share has also afforded it tremendous competitive success within the OBL setting. Medtronic’s atherectomy portfolio especially has generated significant growth for the company within this setting, and is the second-largest revenue generator, overtaking the stent market.
Detailed Market Segmentation
- Peripheral Vascular Stent Market – MedCore – Includes:
- Arterial and Venous PV Stents.
- PTA Balloon Catheter Market – MedCore – Includes:
- Standard, high-pressure, large, small and specialty PTA balloons.
- Drug-Coated Balloon Market – MedCore – Includes:
- SFA drug-coated balloons, BTK drug-coated balloons, and AV access drug-coated balloons.
- Atherectomy Device Market – MedCore – Includes:
- Laser atherectomy devices and mechanical atherectomy disposables.
- Intravascular Lithotripsy Market – MedCore – Includes:
- Hospital intravascular lithotripsy and office-based lab intravascular lithotripsy market segments.
- Chronic Total Occlusion (CTO) Device Market – MedCore – Includes:
- Re-canalization and re-entry devices
- Surgical Graft Market – MedCore – Includes:
- Lower limb surigcal grafts, aorta repair surgical grafts, and extra-anatomical bypass surgical grafts.
- Stent Graft Market – MedCore – Includes:
- abdominal aortic aneurysm (AAA) stent graft segment, the fenestrated (FAA) stent graft segment and the thoracic aortic aneurysm (TAA) stent graft segment
- Embolic Protection Device Market – MedCore – Includes:
- EPDs used in procedures performed in the carotid arteries as well as EPDs used in alternative procedures.
- Peripheral Thrombus Management Device Market – MedCore – Includes:
- Traditional thrombectomy market, pharmaco-mechanical thrombectomy market, and the catheter directed thrombolysis market.
- Inferior Vena Cava Filter & Retrieval Device Market – MedCore – Includes:
- Retrievable IVCF segment, the permanent IVCF segment and the IVCF retrieval device segments.
- Carotid Shunt Market – MedCore – A carotid shunt is a piece of medical tubing used by some physicians in carotid endarterectomy procedures.
- Transcarotid Artery Revascularization Market – MedCore – Includes:
- TCAR neuroprotection system and the TCAR bare-metal stent.
- Diagnostic & Interventional Catheter Market – MedCore – Includes:
-
- Diagnostic catheter segment and the support catheter segment.
-
- Diagnostic & Interventional Guidewire Market – MedCore – Includes:
- Standard Guidewires and Hydrophilic Guidewires.
- Introducer Sheath Market – MedCore – Includes:
- Both standard and guiding introducer sheaths.
- Vascular Closure Device Market – MedCore – Includes:
- Non-invasive vascular closure devices and invasive vascular closure devices.
- Transcatheter Embolization Device Market – MedCore – Includes:
- Embolization particle, the embolization coil, the embolization liquid and the embolization (vascular) plug segments.
- Peripheral IVUS Catheter Market – MedCore – An IVUS system consists of two components: the disposable IVUS catheter and the IVUS consoles.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Region | North America (United States) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
\WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| TABLE of CONTENTS |
| List of Figures |
| List of Charts |
| executive summary |
| U.S. Peripheral Vascular Device Market Overview |
| Competitive Analysis |
| Market Trends |
| Market Developments |
| Procedure Included |
| Procedure Codes Investigated |
| Markets Included |
| Key Report Updates |
| Version History |
| research methodology |
| Step 1: Project Initiation & Team Selection |
| Step 2: Prepare Data Systems and Perform Secondary Research |
| Step 3: Preparation for Interviews & Questionnaire Design |
| Step 4: Performing Primary Research |
| Step 5: Research Analysis: Establishing Baseline Estimates |
| Step 6: Market Forecast and Analysis |
| Step 7: Identify Strategic Opportunities |
| Step 8: Final Review and Market Release |
| Step 9: Customer Feedback and Market Monitoring |
| impact of covid-19 on THE U.S. Peripheral Vascular Device Market |
| 2.1 Introduction |
| 2.2 Analysis By Market Segment |
| 2.2.1 Worst Case Scenario |
| 2.2.2 Base Case Scenario |
| 2.2.3 Best Case Scenario |
| Disease Overview |
| 3.1 Basic Anatomy |
| 3.2 Disease Treatments & Diagnostics |
| 3.2.1 Aortic Aneurysms |
| 3.2.2 Atherosclerosis |
| 3.2.3 Peripheral Arterial Disease (PAD) |
| 3.2.4 Deep Vein Thrombosis |
| 3.2.5 Pulmonary Embolism |
| 3.3 Patient Demographics |
| 3.3.1 Aortic Aneurysms |
| 3.3.2 Atherosclerosis |
| 3.3.3 Peripheral Arterial Disease (PAD) |
| 3.3.4 Deep Vein Thrombosis |
| 3.3.5 Pulmonary Embolism |
| Product Assessment |
| 4.1 Introduction |
| 4.2 Product Portfolios |
| 4.2.1 Peripheral Vascular Stent |
| 4.2.2 PTA Balloon Catheter |
| 4.2.3 Drug-Coated Balloon |
| 4.2.4 Atherectomy Device |
| 4.2.5 Intravascular Lithotripsy Market |
| 4.2.6 Chronic Total Occlusion |
| 4.2.7 Surgical Graft |
| 4.2.8 Stent Graft |
| 4.2.9 Embolic Protection |
| 4.2.10 Peripheral Thrombus Management |
| 4.2.11 Inferior Vena Cava Filter and Retrieval |
| 4.2.12 Carotid Shunt |
| 4.2.13 Transcarotid Artery Revascularization |
| 4.2.14 Diagnostic & Interventional Catheter |
| 4.2.15 Diagnostic and Interventional Guidewire |
| 4.2.16 Introducer Sheath |
| 4.2.17 Vascular Closure Device |
| 4.2.18 Transcatheter Embolization Device |
| 4.2.19 Peripheral IVUS Catheter |
| 4.3 Regulatory Issues and Recalls |
| 4.3.1 Peripheral Vascular Stent |
| 4.3.1.1 Becton Dickinson |
| 4.3.1.2 Boston Scientific |
| 4.3.1.3 Cardinal Health |
| 4.3.1.4 Cook Medical |
| 4.3.1.5 Maquet |
| 4.3.1.6 Medtronic |
| 4.3.1.7 Silk Road Medical |
| 4.3.1.8 W.L. Gore |
| 4.3.2 PTA Balloon Catheter |
| 4.3.2.1 Becton Dickinson |
| 4.3.2.2 Cardinal Health |
| 4.3.2.3 Cook Medical |
| 4.3.2.4 Medtronic |
| 4.3.3 Atherectomy Device |
| 4.3.3.1 Boston Scientific |
| 4.3.3.2 Cardiovascular Systems Inc. |
| 4.3.3.3 Medtronic |
| 4.3.4 Intravascular Lithotripsy Market |
| 4.3.4.1 Shockwave Medical |
| 4.3.5 Introducer Sheaths |
| 4.3.6 Peripheral Thrombus Management Devices |
| 4.3.7 Chronic Total Occlusion |
| 4.3.7.1 Edwards Lifesciences |
| 4.3.8 Surgical Graft |
| 4.3.8.1 Maquet |
| 4.3.8.2 Terumo |
| 4.3.8.3 W.L. Gore |
| 4.3.9 Stent Graft |
| 4.3.9.1 Endologix |
| 4.3.9.2 Cook Medical |
| 4.3.9.3 Medtronic |
| 4.3.10 Peripheral Thrombus Management |
| 4.3.10.1 Boston Scientific |
| 4.3.10.2 Teleflex |
| 4.3.11 Inferior Vena Cava Filter & Retrieval |
| 4.3.11.1 Cook Medical |
| 4.3.12 Transcarotid Artery Revascularization |
| 4.3.12.1 Silk Road Medical |
| 4.3.13 Diagnostic & Interventional Catheter |
| 4.3.13.1 AngioDynamics |
| 4.3.13.2 Becton Dickinson |
| 4.3.13.3 Boston Scientific |
| 4.3.13.4 Cardinal Health |
| 4.3.13.5 Cook Medical |
| 4.3.14 Diagnostic & Interventional Guidewire |
| 4.3.14.1 Cook Medical |
| 4.3.15 Introducer Sheath |
| 4.3.15.1 Abbott |
| 4.3.15.2 Cardinal Health |
| 4.3.15.3 Cook Medical |
| 4.3.16 Transcatheter Embolization Device |
| 4.3.16.1 Cook Medical |
| 4.3.16.2 Terumo |
| 4.3.17 Peripheral IVUS Catheter |
| 4.3.17.1 Boston Scientific |
| 4.4 Clinical Trials |
| 4.4.1 Peripheral Vascular Stent |
| 4.4.2 PTA Balloon Catheter |
| 4.4.3 Drug-Coated Balloon |
| 4.4.4 Atherectomy Device |
| 4.4.5 Intravascular Lithotripsy |
| 4.4.6 Surgical Graft |
| 4.4.7 Stent Graft |
| 4.4.8 Embolic Protection |
| 4.4.9 Peripheral Thrombus Management |
| 4.4.10 Inferior Vena Cava Filter & Retrieval |
| 4.4.11 Transcarotid Artery Revascularization |
| 4.4.12 Vascular Closure Device |
| 4.4.13 Transcatheter Embolization Device |
| U.S. Peripheral Vascular Device Market Overview |
| 5.1 Introduction |
| 5.1.1 Atherosclerosis |
| 5.1.2 Peripheral Arterial Disease (PAD) |
| 5.2 Market Overview & Trend Analysis |
| 5.3 Drivers and Limiters |
| 5.3.1 Market Drivers |
| 5.3.2 Market Limiters |
| 5.4 Competitive Market Share Analysis |
| 5.5 Mergers and Acquisitions |
| 5.6 Company Profiles |
| 5.6.1 Abbott |
| 5.6.2 Becton Dickinson |
| 5.6.3 Boston Scientific |
| 5.6.4 Cardinal Health |
| 5.6.5 Cardiovascular Systems, Inc. |
| 5.6.6 Cook Medical |
| 5.6.7 Medtronic |
| 5.6.8 Penumbra |
| 5.6.9 Philips |
| 5.6.10 Shockwave Medical |
| 5.6.11 Silk Road Medical |
| 5.6.12 Terumo |
| 5.6.13 W.L. Gore |
| 5.7 SWOT Analysis |
| 5.7.1 Abbott |
| 5.7.2 Becton Dickinson |
| 5.7.3 Boston Scientific |
| 5.7.4 Cardinal Health |
| 5.7.5 Cardiovascular Systems, Inc. |
| 5.7.6 Cook Medical |
| 5.7.7 Medtronic |
| 5.7.8 Penumbra |
| 5.7.9 Philips |
| 5.7.10 Shockwave Medical |
| 5.7.11 Silk Road Medical |
| 5.7.12 Terumo |
| 5.7.13 W.L. Gore |
| Procedure Numbers |
| 6.1 Introduction |
| 6.2 Procedures |
| 6.2.1 Total Peripheral Vascular Procedures |
| 6.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting |
| 6.2.2.1 Above-the-Knee Procedures |
| 6.2.2.1.1 Above-the-Knee Stent Procedures |
| 6.2.2.1.2 Above-the-Knee POBA Procedures by Care Setting |
| 6.2.2.1.3 Above-the-Knee DCB Procedures by Care Setting |
| 6.2.2.1.4 Intravascular Lithotripsy Procedures |
| 6.2.2.1.5 Above-the-Knee Atherectomy without Stent Procedures by Care Setting |
| 6.2.2.1.6 Above-the-Knee Atherectomy with Stent Procedures by Care Setting |
| 6.2.2.1.7 Surgical Graft Procedures |
| 6.2.2.2 Below-the-Knee Procedures |
| 6.2.2.2.1 Below-the-Knee Stent Procedures |
| 6.2.2.2.2 Below-the-Knee POBA Procedures by Care Setting |
| 6.2.2.2.3 Below-the-Knee DCB Procedures by Care Setting |
| 6.2.2.2.4 Intravascular Lithotripsy Procedures |
| 6.2.2.2.5 Below-the-Knee Atherectomy without Stent Procedures by Care Setting |
| 6.2.2.2.6 Below-the-Knee Atherectomy with Stent Procedures by Care Setting |
| 6.2.2.2.7 Surgical Graft Procedures |
| 6.2.2.3 Iliac Procedures |
| 6.2.2.3.1 Iliac Stent Procedures |
| 6.2.2.3.2 Iliac POBA Procedures by Care Setting |
| 6.2.2.4 AV Access Procedures |
| 6.2.2.4.1 AV Access Covered Stent Procedures by Care Setting |
| 6.2.2.4.2 AV Access POBA Procedures by Care Setting |
| 6.2.2.4.3 AV Access DCB Procedures by Care Setting |
| 6.2.2.5 Renal Procedures |
| 6.2.2.6 Carotid Procedures |
| 6.2.3 Peripheral Vascular Stent Procedures |
| 6.2.3.1 Peripheral Arterial Stent Procedures |
| 6.2.3.1.1 Bare-Metal Stent Procedures |
| 6.2.3.1.2 Covered Stent Procedures |
| 6.2.3.1.3 Drug-Eluting Stent Procedures |
| 6.2.3.2 Peripheral Venous Stent Procedures |
| 6.2.4 PTA Balloon Catheter Procedures |
| 6.2.5 Drug-Coated Balloon Procedures |
| 6.2.5.1 Drug-Coated Balloon Procedures by Care Setting |
| 6.2.5.2 Drug-Coated Balloon Procedures by Indication |
| 6.2.6 Atherectomy Procedures |
| 6.2.6.1 Atherectomy Procedures by Device Type |
| 6.2.6.2 Atherectomy Procedures by Indication |
| 6.2.6.2.1 Fem-Popliteal Artery Atherectomy Procedures by Type |
| 6.2.6.2.2 Infra-Popliteal Artery Atherectomy Procedures by Type |
| 6.2.6.3 Atherectomy Procedures by Care Setting |
| 6.2.7 Intravascular Lithotripsy Procedures |
| 6.2.7.1.1 Intravascular Lithotripsy Procedures by Indication |
| 6.2.8 CTO Device Procedures |
| 6.2.8.1 CTO Device Procedures by Type |
| 6.2.9 Surgical Graft Procedures |
| 6.2.9.1 Surgical Graft Procedures by Graft Material |
| 6.2.9.2 Surgical Graft Procedures by Indication |
| 6.2.9.2.1 Lower Limb Surgical Graft Procedures by Anatomy |
| 6.2.9.2.2 Aorta Repair Surgical Graft Procedures by Anatomy |
| 6.2.10 Stent Graft Procedures |
| 6.2.10.1 Endovascular Stent Graft Procedures by Type |
| 6.2.10.2 EVAR Procedures |
| 6.2.10.2.1 EVAR Procedures by Anatomy |
| 6.2.10.2.2 EVAR Procedures by Device Type |
| 6.2.10.2.3 EVAR Procedures by Complexity |
| 6.2.10.2.4 EVAR Procedures by Fenestration |
| 6.2.10.2.5 EVAR Procedures by Anesthesia Type |
| 6.2.10.2.6 EVAR Procedures by Gender |
| 6.2.10.3 TEVAR Procedures |
| 6.2.10.3.1 TEVAR Procedures by Indication |
| 6.2.10.3.2 TEVAR Procedures by Anesthesia Type |
| 6.2.10.3.3 TEVAR Procedures by Gender |
| 6.2.11 Embolic Protection Procedures |
| 6.2.11.1 Embolic Protection Procedures by Type |
| 6.2.12 Peripheral Thrombus Management Procedures |
| 6.2.12.1 Peripheral Thrombus Management Procedures by Procedure Type |
| 6.2.12.2 Peripheral Thrombus Management Procedures by Indication |
| 6.2.13 Inferior Vena Cava Filter Procedures |
| 6.2.13.1 Inferior Vena Cava Filter Procedures by Procedure Type |
| 6.2.13.1.1 IVCF Placement Procedures by Device Type |
| 6.2.14 Carotid Intervention Procedures |
| 6.2.14.1 Carotid Intervention Procedures by Procedure Type |
| 6.2.15 Vascular Closure Device Procedures |
| 6.2.15.1 Vascular Closure Device Procedures by Device Type |
| 6.2.15.1.1 Invasive Vascular Closure Procedures by Device Size |
| 6.2.15.2 Vascular Closure Procedures by Approach |
| 6.2.16 Transcatheter Embolization Procedures |
| 6.2.16.1 Transcatheter Embolization Procedures by Device Type |
| 6.2.16.1.1 Transcatheter Particle Embolization Procedures by Device Type |
| 6.2.16.1.2 Transcatheter Coil Embolization Procedures by Device Type |
| 6.2.17 Peripheral IVUS Procedures |
| 6.2.17.1 Peripheral IVUS Procedures by Indication |
| 6.2.17.2 Peripheral IVUS Procedures by Care Setting |
| Peripheral Vascular Stent Market |
| 7.1 Introduction |
| 7.1.1 Peripheral Arterial Stents |
| 7.1.1.1 Off-Label Use |
| 7.1.1.2 Covered Stents |
| 7.1.1.3 Drug-Eluting Stents |
| 7.1.1.4 Infrapopliteal Stenting |
| 7.1.1.5 Stent Length |
| 7.1.1.6 General Information |
| 7.1.2 Venous Stents |
| 7.2 Market Overview |
| 7.3 Market Analysis and Forecast |
| 7.3.1 Peripheral Arterial Stent Market |
| 7.3.1.1 Total Bare-Metal Peripheral Arterial Stent Market |
| 7.3.1.1.1 Bare-Metal Peripheral Arterial Stent Market by Indication |
| 7.3.1.1.2 Bare-Metal Carotid Stent Market |
| 7.3.1.1.3 Bare-Metal Iliac Stent Market |
| 7.3.1.1.4 Bare-Metal Renal Stent Market |
| 7.3.1.1.5 Bare-Metal Fem-Popliteal Stent Market |
| 7.3.1.1.6 Bare-Metal Infra-Popliteal Stent Market |
| 7.3.1.1.7 Bare-Metal Stent Market by Delivery Platform |
| 7.3.1.1.8 Self-Expanding Bare-Metal Stent Market |
| 7.3.1.1.9 Balloon Expanding Bare-Metal Stent Market |
| 7.3.1.2 Total Covered Stent Market |
| 7.3.1.2.1 Iliac Covered Stent Market |
| 7.3.1.2.2 Fem-Popliteal Covered Stent Market |
| 7.3.1.2.3 AV Access Covered Stent Market |
| 7.3.1.3 Total Drug-Eluting Stent Market |
| 7.3.1.3.1 SFA Drug-Eluting Stent Market |
| 7.3.1.3.2 Infra-Popliteal Drug-Eluting Stent Market |
| 7.3.2 Venous Stent Market |
| 7.4 Unit Analysis |
| 7.4.1 Units Sold by Stent Length |
| 7.4.1.1 Bare-Metal Carotid Stent Units |
| 7.4.1.2 Bare-Metal Renal Stent Units |
| 7.4.1.3 Bare-Metal Iliac Stent Units |
| 7.4.1.4 Bare-Metal Fem-Popliteal Stent Units |
| 7.5 Drivers and Limiters |
| 7.5.1 Market Drivers |
| 7.5.2 Market Limiters |
| 7.6 Competitive Market Share Analysis |
| PTA Balloon Catheter Market |
| 8.1 Introduction |
| 8.2 Market Overview |
| 8.3 Market Analysis and Forecast |
| 8.3.1 Total PTA Balloon Catheter Market |
| 8.3.2 Total Standard PTA Balloon Catheter Market |
| 8.3.2.1 Hospital Standard PTA Balloon Catheter Market |
| 8.3.2.2 Office-Based Lab Standard PTA Balloon Catheter Market |
| 8.3.3 Total High-Pressure PTA Balloon Catheter Market |
| 8.3.3.1 Hospital High-Pressure PTA Balloon Catheter Market |
| 8.3.3.2 Office-Based Lab High-Pressure PTA Balloon Catheter Market |
| 8.3.4 Total Large PTA Balloon Catheter Market |
| 8.3.4.1 Hospital Large PTA Balloon Catheter Market |
| 8.3.4.2 Office-Based Lab Large PTA Balloon Catheter Market |
| 8.3.5 Total Small PTA Balloon Catheter Market |
| 8.3.5.1 Small PTA Balloon Catheter Market by Balloon Size |
| 8.3.5.1.1 0.014” Small PTA Balloon Catheter Market |
| 8.3.5.1.2 0.018” Small PTA Balloon Catheter Market |
| 8.3.5.2 Small PTA Balloon Catheter Market by Care Setting |
| 8.3.5.2.1 Hospital Small PTA Balloon Catheter Market |
| 8.3.5.2.2 Office-Based Lab Small PTA Balloon Catheter Market |
| 8.3.6 Total Specialty PTA Balloon Catheter Market |
| 8.3.6.1 Hospital Specialty PTA Balloon Catheter Market |
| 8.3.6.2 Office-Based Lab Specialty PTA Balloon Catheter Market |
| 8.4 Unit Analysis |
| 8.4.1 Units Sold by Application |
| 8.5 Drivers and Limiters |
| 8.5.1 Market Drivers |
| 8.5.2 Market Limiters |
| 8.6 Competitive Market Share Analysis |
| 8.6.1 Standard PTA Balloon Catheter Market |
| 8.6.2 High-Pressure PTA Balloon Catheter Market |
| 8.6.3 Large PTA Balloon Catheter Market |
| 8.6.4 Small PTA Balloon Catheter Market |
| 8.6.5 Specialty PTA Balloon Catheter Market |
| Drug-Coated Balloon Market |
| 9.1 Introduction |
| 9.2 Market Overview |
| 9.3 Market Analysis and Forecast |
| 9.3.1 Total Drug-Coated Balloon Market |
| 9.3.1.1 SFA Drug-Coated Balloon Market |
| 9.3.1.2 BTK DCB Market |
| 9.3.1.3 AV Access DCB Market |
| 9.4 Unit Analysis |
| 9.4.1 Units Sold by Care Setting |
| 9.5 Drivers and Limiters |
| 9.5.1 Market Drivers |
| 9.5.2 Market Limiters |
| 9.6 Competitive Market Share Analysis |
| 9.6.1 Emerging Competitors |
| Atherectomy Device Market |
| 10.1 Introduction |
| 10.2 Market Overview |
| 10.3 Market Analysis and Forecast |
| 10.3.1 Atherectomy Device Market by Technology |
| 10.3.1.1 Total Laser Atherectomy Device Market |
| 10.3.1.1.1 Laser Atherectomy Disposable Market |
| 10.3.1.1.2 Laser Atherectomy Console Market |
| 10.3.1.2 Mechanical Atherectomy Disposable Market |
| 10.3.2 Atherectomy Disposable Market by Care Setting |
| 10.3.2.1 Hospital Atherectomy Disposable Market |
| 10.3.2.2 Office-Based Lab Atherectomy Disposable Market |
| 10.4 Drivers and Limiters |
| 10.4.1 Market Drivers |
| 10.4.2 Market Limiters |
| 10.5 Competitive Market Share Analysis |
| Intravascular Lithotripsy Market |
| 11.1 Introduction |
| 11.2 Market Analysis and Forecast |
| 11.2.1 Intravascular Lithotripsy Market by Care Setting |
| 11.2.1.1 Hospital Intravascular Lithotripsy Market |
| 11.2.1.2 Office-Based Lab Intravascular Lithotripsy Market |
| 11.3 Drivers and Limiters |
| 11.3.1 Market Drivers |
| 11.3.2 Market Limiters |
| 11.4 Competitive Market Share Analysis |
| CTO Device Market |
| 12.1 Introduction |
| 12.2 Market Overview |
| 12.3 Market Analysis and Forecast |
| 12.3.1 Total CTO Device Market |
| 12.3.2 Re-Entry Device Market |
| 12.3.3 Re-Canalization Device Market |
| 12.4 Drivers and Limiters |
| 12.4.1 Market Drivers |
| 12.4.2 Market Limiters |
| 12.5 Competitive Market Share Analysis |
| Surgical Graft Market |
| 13.1 Introduction |
| 13.2 Market Overview |
| 13.2.1 Surgical Graft Market Overview by Indication |
| 13.2.2 Surgical Graft Market Overview by Material |
| 13.3 Market Analysis and Forecast |
| 13.3.1 Total Surgical Graft Market |
| 13.3.2 Surgical Graft Market by Indication |
| 13.3.2.1 Total Lower Limb Surgical Graft Market |
| 13.3.2.1.1 Above-the-Knee Surgical Graft Market |
| 13.3.2.1.2 Below-the-Knee Surgical Graft Market |
| 13.3.2.2 Total Aorta Repair Surgical Graft Market |
| 13.3.2.2.1 Abdominal Aortic Aneurysm Surgical Graft Market |
| 13.3.2.2.2 Thoracic Aortic Aneurysm Surgical Graft Market |
| 13.3.2.3 Extra-Anatomical Bypass Surgical Graft Market |
| 13.3.3 Surgical Graft Market by Material |
| 13.3.3.1 Polyester Surgical Graft Market |
| 13.3.3.2 ePTFE Surgical Graft Market |
| 13.4 Drivers and Limiters |
| 13.4.1 Market Drivers |
| 13.4.2 Market Limiters |
| 13.5 Competitive Market Share Analysis |
| Stent Graft Market |
| 14.1 Introduction |
| 14.2 Market Overview |
| 14.3 Market Analysis and Forecast |
| 14.3.1 Total Stent Graft Market |
| 14.3.2 Total AAA Stent Graft Market |
| 14.3.2.1 Bifurcated Main Body Graft Market |
| 14.3.2.2 Contralateral/Ipsilateral Iliac Leg/Limb Market |
| 14.3.2.3 Aorto-uni-iliac (AUI) Stent Graft Market |
| 14.3.2.4 Iliac Extension Market |
| 14.3.2.5 Aortic Extension Market |
| 14.3.3 Total FAA Stent Graft Market |
| 14.3.3.1 Fenestrated Distal Bifurcated Graft Market |
| 14.3.3.2 Fenestrated Proximal Body Graft Market |
| 14.3.4 TAA Stent Graft Market |
| 14.4 Drivers and Limiters |
| 14.4.1 Market Drivers |
| 14.4.2 Market Limiters |
| 14.5 Competitive Market Share Analysis |
| Embolic Protection Device Market |
| 15.1 Introduction |
| 15.1.1 New Applications |
| 15.1.2 Protection Mechanism |
| 15.1.2.1 Filter Devices |
| 15.1.2.2 Balloon Occlusion Systems |
| 15.1.2.3 Flow Redirection |
| 15.2 Market Overview |
| 15.3 Market Analysis and Forecast |
| 15.3.1 Total Embolic Protection Device Market |
| 15.3.2 Carotid EPD Market |
| 15.3.3 Total Alternative EPD Market |
| 15.3.3.1 Renal EPD Market |
| 15.3.3.2 Lower Limb EPD Market |
| 15.4 Drivers and Limiters |
| 15.4.1 Market Drivers |
| 15.4.2 Market Limiters |
| 15.5 Competitive Market Share Analysis |
| Peripheral Thrombus Management Market |
| 16.1 Introduction |
| 16.1.1 AV Access Thrombectomy Devices |
| 16.1.2 Other Peripheral Applications of Thrombectomy Devices |
| 16.2 Market Overview |
| 16.2.1 Peripheral Thrombus Management Market Overview by Device Type |
| 16.2.2 Peripheral Thrombus Management Market Overview by Indication |
| 16.3 Market Analysis and Forecast |
| 16.3.1 Total Peripheral Thrombus Management Market |
| 16.3.2 Peripheral Thrombus Management Market by Device Type |
| 16.3.2.1 Traditional Thrombectomy Market |
| 16.3.2.2 Pharmacomechanical Thrombectomy Market |
| 16.3.2.3 Catheter Directed Thrombolysis Market |
| 16.3.3 Peripheral Thrombus Management Market by Indication |
| 16.3.3.1 AV Access Thrombectomy Device Market |
| 16.3.3.2 Arterial Thrombectomy Device Market |
| 16.3.3.3 Venous Thrombectomy Device Market |
| 16.4 Drivers and Limiters |
| 16.4.1 Market Drivers |
| 16.4.2 Market Limiters |
| 16.5 Competitive Market Share Analysis |
| Inferior Vena Cava Filter & RetriEval Device Market |
| 17.1 Introduction |
| 17.2 Market Overview |
| 17.3 Market Analysis and Forecast |
| 17.3.1 Total Inferior Vena Cava Filter & Retrieval Device Market |
| 17.3.1.1 Retrievable IVCF Market |
| 17.3.1.2 Permanent IVCF Market |
| 17.3.2 IVCF Retrieval Device Market |
| 17.4 Drivers and Limiters |
| 17.4.1 Market Drivers |
| 17.4.2 Market Limiters |
| 17.5 Competitive Market Share Analysis |
| Carotid Shunt Market |
| 18.1 Introduction |
| 18.2 Market Analysis and Forecast |
| 18.3 Drivers and Limiters |
| 18.3.1 Market Drivers |
| 18.3.2 Market Limiters |
| 18.4 Competitive Market Share Analysis |
| Transcarotid Artery Revascularization Market |
| 19.1 Introduction |
| 19.2 Market Overview |
| 19.3 Market Analysis and Forecast |
| 19.3.1 Transcarotid Bare-Metal Stent Market |
| 19.3.2 TCAR Neuroprotection System Market |
| 19.4 Drivers and Limiters |
| 19.4.1 Market Drivers |
| 19.4.2 Market Limiters |
| 19.5 Competitive Market Share Analysis |
| Diagnostic & Interventional Catheter Market |
| 20.1 Introduction |
| 20.2 Market Overview |
| 20.3 Market Analysis and Forecast |
| 20.3.1 Total Diagnostic & Interventional Catheter Market |
| 20.3.2 Total Diagnostic Catheter Market |
| 20.3.2.1 Standard Diagnostic Catheter Market |
| 20.3.2.2 Hydrophilic Diagnostic Catheter Market |
| 20.3.3 Support Catheter Market |
| 20.4 Drivers and Limiters |
| 20.4.1 Market Drivers |
| 20.4.2 Market Limiters |
| 20.5 Competitive Market Share Analysis |
| Diagnostic & Interventional Guidewire Market |
| 21.1 Introduction |
| 21.2 Market Overview |
| 21.3 Market Analysis and Forecast |
| 21.3.1 Total Diagnostic & Interventional Guidewire Market |
| 21.3.2 Standard Guidewire Market |
| 21.3.3 Hydrophilic Guidewire Market |
| 21.4 Drivers and Limiters |
| 21.4.1 Market Drivers |
| 21.4.2 Market Limiters |
| 21.5 Competitive Market Share Analysis |
| Introducer Sheath Market |
| 22.1 Introduction |
| 22.2 Market Overview |
| 22.3 Market Analysis and Forecast |
| 22.3.1 Total Introducer Sheath Market |
| 22.3.2 Standard Introducer Sheath Market |
| 22.3.3 Guiding Introducer Sheath Market |
| 22.4 Drivers and Limiters |
| 22.4.1 Market Drivers |
| 22.4.2 Market Limiters |
| 22.5 Competitive Market Share Analysis |
| Vascular Closure Device Market |
| 23.1 Introduction |
| 23.2 Market Overview |
| 23.2.1 Vascular Closure Device Market Overview by Device Type |
| 23.2.2 Vascular Closure Device Market Overview by Approach |
| 23.3 Market Analysis and Forecast |
| 23.3.1 Total Vascular Closure Device Market |
| 23.3.2 Vascular Closure Device Market by Device Type |
| 23.3.2.1 Non-Invasive Vascular Closure Device Market |
| 23.3.2.2 Total Invasive Vascular Closure Device Market |
| 23.3.2.2.1 Small-Bore Invasive VCD Market |
| 23.3.2.2.2 Large-Bore Invasive VCD Market |
| 23.3.3 Vascular Closure Device Market by Approach |
| 23.3.3.1 Radial VCD Market |
| 23.3.3.2 Femoral VCD Market |
| 23.4 Drivers and Limiters |
| 23.4.1 Market Drivers |
| 23.4.2 Market Limiters |
| 23.5 Competitive Market Share Analysis |
| Transcatheter Embolization Device Market |
| 24.1 Introduction |
| 24.1.1 Particle Embolics |
| 24.1.2 Coil Embolics |
| 24.1.3 Liquid Embolics |
| 24.1.4 Vascular Plugs |
| 24.2 Market Overview |
| 24.3 Market Analysis and Forecast |
| 24.3.1 Total Transcatheter Embolization Device Market |
| 24.3.2 Total Embolization Particle Market |
| 24.3.2.1 PVA Embolization Particle Market |
| 24.3.2.2 Microsphere Embolization Particle Market |
| 24.3.2.3 Drug-Eluting Embolization Particle Market |
| 24.3.2.4 Radioactive Embolization Particle Market |
| 24.3.3 Total Embolization Coil Market |
| 24.3.3.1 Pushable Coil Market |
| 24.3.3.2 Detachable Coil Market |
| 24.3.4 Embolization Liquid Market |
| 24.3.5 Embolization Plug Market |
| 24.4 Drivers and Limiters |
| 24.4.1 Market Drivers |
| 24.4.2 Market Limiters |
| 24.5 Competitive Market Share Analysis |
| Peripheral IVUS Catheter Market |
| 25.1 Introduction |
| 25.2 Market Analysis and Forecast |
| 25.3 Drivers and Limiters |
| 25.3.1 Market Drivers |
| 25.3.2 Market Limiters |
| 25.4 Competitive Market Share Analysis |
| Abbreviations |
Companies Included:
| · Abbott Vascular | · Infraredx |
| · Acist Medical | · Integra LifeSciences |
| · Advanced Vascular Dynamics | · LeMaitre Vascular |
| · ALN International | · Lucas Medical |
| · AngioDynamics | · Maquet |
| · Argon Medical | · Marine Polymer Technologies |
| · ArtVentive | · Medline |
| · Ashai Intecc USA Inc. | · Medtronic |
| · Avinger | · Merit Medical |
| · B. Braun | · Mermaid Medical |
| · Balt | · Micro Medical Solutions |
| · Baylis Medical | · Morris Innovative Inc. |
| · Becton Dickinson | · Navilyst Medical |
| · Biotronik | · Nipro |
| · Blockade Medical | · NuCryo Vascular |
| · Boston Scientific | · Okami Medical |
| · Cardinal Health | · Oscor |
| · Cardiovascular Systems, Inc. | · Penumbra |
| · Cardiva | · Pfizer |
| · Cerenovus | · PFM Medical |
| · CME | · Philips |
| · Concordance Healthcare | · Provisio Medical |
| · Consolidated Service Center | · Ra Medical |
| · Contego Medical | · Radius Medical |
| · Control Medical Technology | · Reflow Medical |
| · Cook Medical | · Rex Medical |
| · Edwards LifeSciences | · Roxwood Medical |
| · Endologix | · Shockwave Medical |
| · HemCon Medical Technologies | · Silk Road Medical |
| · Inari Medical | · Sirtex |
| · Surmodics | · TZ Medical |
| · Teleflex | · Varian Medical Systems |
| · Terumo | · Vascular Flow Technologies |
| · Thrombolex | · Veryan Medical |
| · Tricol Biomedical | · W.L. Gore |
List of Charts
| Chart 1‑1: Peripheral Vascular Device Market by Segment, U.S., 2022 – 2029 |
| Chart 1‑2: Peripheral Vascular Device Market Overview, U.S., 2022 & 2029 |
| Chart 2‑1: Multi-Scenario Peripheral Vascular Device Market Forecast, U.S., 2019 – 2029 (US$M) |
| Chart 5‑1: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 |
| Chart 5‑2: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 |
| Chart 6‑1: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 |
| Chart 7‑1: Peripheral Vascular Stent Market by Segment, U.S., 2019 – 2029 |
| Chart 7‑2: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2022 |
| Chart 8‑1: PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 |
| Chart 8‑2: Leading Competitors, PTA Balloon Catheter Market, U.S., 2022 |
| Chart 9‑1: Drug-Coated Balloon Market by Segment, U.S., 2019 – 2029 |
| Chart 9‑2: Leading Competitors, Drug-Coated Balloon Market, U.S., 2022 |
| Chart 10‑1: Atherectomy Device Market by Segment, U.S., 2019 – 2029 |
| Chart 10‑2: Leading Competitors, Atherectomy Device Market, U.S., 2022 |
| Chart 11‑1: Intravascular Lithotripsy Market by Care Setting, U.S., 2019 – 2029 |
| Chart 12‑1: CTO Device Market by Segment, U.S., 2019 – 2029 |
| Chart 12‑2: Leading Competitors, CTO Device Market, U.S., 2022 |
| Chart 13‑1: Surgical Graft Market by Indication, U.S., 2019 – 2029 |
| Chart 13‑2: Surgical Graft Market by Material, U.S., 2019 – 2029 |
| Chart 13‑3: Leading Competitors, Surgical Graft Market, U.S., 2022 |
| Chart 14‑1: Stent Graft Market by Segment, U.S., 2019 – 2029 |
| Chart 14‑2: Leading Competitors, Stent Graft Market, U.S., 2022 |
| Chart 15‑1: Embolic Protection Device Market by Segment, U.S., 2019 – 2029 |
| Chart 15‑2: Leading Competitors, Embolic Protection Device Market, U.S., 2022 |
| Chart 16‑1: Peripheral Thrombus Management Market Overview by Device Type, U.S., 2019 – 2029 |
| Chart 16‑2: Peripheral Thrombus Management Market Overview by Indication, U.S., 2019 – 2029 |
| Chart 16‑3: Leading Competitors, Peripheral Thrombus Management Market, U.S., 2022 |
| Chart 17‑1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2019 – 2029 |
| Chart 17‑2: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2022 |
| Chart 18‑1: Carotid Shunt Market, U.S., 2019 – 2029 |
| Chart 18‑2: Leading Competitors, Carotid Shunt Market, U.S., 2022 |
| Chart 19‑1: Transcarotid Artery Revascularization Market by Segment, U.S., 2019 – 2029 |
| Chart 20‑1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2019 – 2029 |
| Chart 20‑2: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2022 |
| Chart 21‑1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2019 – 2029 |
| Chart 21‑2: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2022 |
| Chart 22‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029 |
| Chart 22‑2: Leading Competitors, Introducer Sheath Market, U.S., 2022 |
| Chart 23‑1: Vascular Closure Device Market by Device Type, U.S., 2019 – 2029 |
| Chart 23‑2: Vascular Closure Device Market by Approach, U.S., 2019 – 2029 |
| Chart 23‑3: Leading Competitors, Vascular Closure Device Market, U.S., 2022 |
| Chart 24‑1: Transcatheter Embolization Device Market by Segment, U.S., 2019 – 2029 |
| Chart 24‑2: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2022 |
| Chart 25‑1: Peripheral IVUS Catheter Market, U.S., 2019 – 2029 |
| Chart 25‑2: Leading Competitors, Peripheral IVUS Catheter Market, U.S., 2022 |
List of Figures
| Figure 1‑1: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (1 of 4) |
| Figure 1‑2: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (2 of 4) |
| Figure 1‑3: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (3 of 4) |
| Figure 1‑4: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2022 (4 of 4) |
| Figure 1‑5: Companies Researched in this Report (1 of 2) |
| Figure 1‑6: Companies Researched in this Report (2 of 2) |
| Figure 1‑7: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (1 of 4) |
| Figure 1‑8: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (2 of 4) |
| Figure 1‑9: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (3 of 4) |
| Figure 1‑10: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (4 of 4) |
| Figure 1‑11: Recent Events in the Peripheral Vascular Device Market, U.S., 2019 – 2022 |
| Figure 1‑12: Peripheral Vascular Device Procedures Covered by Indication (1 of 3) |
| Figure 1‑13: Peripheral Vascular Device Procedures Covered by Indication (2 of 3) |
| Figure 1‑14: Peripheral Vascular Device Procedures Covered by Indication (3 of 3) |
| Figure 1‑15: Peripheral Vascular Device Procedures Covered by Device Type (1 of 5) |
| Figure 1‑16: Peripheral Vascular Device Procedures Covered by Device Type (2 of 5) |
| Figure 1‑17: Peripheral Vascular Device Procedures Covered by Device Type (3 of 5) |
| Figure 1‑18: Peripheral Vascular Device Procedures Covered by Device Type (4 of 5) |
| Figure 1‑19: Peripheral Vascular Device Procedures Covered by Device Type (5 of 5) |
| Figure 1‑20: Procedure Codes Investigated |
| Figure 1‑21: Peripheral Vascular Device Markets Covered (1 of 5) |
| Figure 1‑22: Peripheral Vascular Device Markets Covered (2 of 5) |
| Figure 1‑23: Peripheral Vascular Device Markets Covered (3 of 5) |
| Figure 1‑24: Peripheral Vascular Device Markets Covered (4 of 5) |
| Figure 1‑25: Peripheral Vascular Device Markets Covered (5 of 5) |
| Figure 1‑26: Key Report Updates |
| Figure 1‑27: Version History |
| Figure 2‑1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3) |
| Figure 2‑2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3) |
| Figure 2‑3: Peripheral Vascular Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3) |
| Figure 2‑4: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3) |
| Figure 2‑5: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3) |
| Figure 2‑6: Peripheral Vascular Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3) |
| Figure 2‑7: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (1 of 3) |
| Figure 2‑8: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (2 of 3) |
| Figure 2‑9: Peripheral Vascular Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) (3 of 3) |
| Figure 4‑1: Peripheral Vascular Stent by Company (1 of 2) |
| Figure 4‑2: Peripheral Vascular Stent by Company (2 of 2) |
| Figure 4‑3: PTA Balloon Catheter by Company (1 of 3) |
| Figure 4‑4: PTA Balloon Catheter by Company (2 of 3) |
| Figure 4‑5: PTA Balloon Catheter by Company (3 of 3) |
| Figure 4‑6: Drug-Coated Balloon by Company |
| Figure 4‑7: Atherectomy Device by Company (1 of 2) |
| Figure 4‑8: Atherectomy Device by Company (2 of 2) |
| Figure 4‑9: Lithotripsy Device by Company |
| Figure 4‑10: Chronic Total Occlusion Device by Company |
| Figure 4‑11: Surgical Graft by Company (1 of 2) |
| Figure 4‑12: Surgical Graft by Company (2 of 2) |
| Figure 4‑13: Stent Graft by Company |
| Figure 4‑14: Embolic Protection Device by Company |
| Figure 4‑15: Peripheral Thrombus Management by Company |
| Figure 4‑16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2) |
| Figure 4‑17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2) |
| Figure 4‑18: Carotid Shunt by Company |
| Figure 4‑19: Transcarotid Artery Revascularization Device by Company |
| Figure 4‑20: Diagnostic and Interventional Catheters by Company (1 of 2) |
| Figure 4‑21: Diagnostic and Interventional Catheters by Company (2 of 2) |
| Figure 4‑22: Diagnostic and Interventional Guidewire by Company (1 of 3) |
| Figure 4‑23: Diagnostic and Interventional Guidewire by Company (2 of 3) |
| Figure 4‑24: Diagnostic and Interventional Guidewire by Company (3 of 3) |
| Figure 4‑25: Introducer Sheath by Company (1 of 2) |
| Figure 4‑26: Introducer Sheath by Company (2 of 2) |
| Figure 4‑27: Vascular Closure Device by Company |
| Figure 4‑28: Transcatheter Embolization Devices by Company (1 of 2) |
| Figure 4‑29: Transcatheter Embolization Devices by Company (2 of 2) |
| Figure 4‑30: Peripheral IVUS Catheter by Company |
| Figure 4‑31: Class 2 Device Recall VENOVO Venous Stent System |
| Figure 4‑32: Class 1 Device Recall VICI VENOUS STENT System |
| Figure 4‑33: Class 2 Device Recall ELUVIA |
| Figure 4‑34: Class 2 Device Recall PALMAZ GENESIS |
| Figure 4‑35: Class 2 Device Recall S.M.A.R.T. Flex |
| Figure 4‑36: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System |
| Figure 4‑37: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System |
| Figure 4‑38: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System |
| Figure 4‑39: Class 2 Device Recall Cordis Precise Nitinol Stent System |
| Figure 4‑40: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent |
| Figure 4‑41: Class 2 Device Recall Zilver 635 Biliary Stent |
| Figure 4‑42: Class 2 Device Recall Zilver 518 Biliary Stent |
| Figure 4‑43: Class 1 Device Recall Atrium |
| Figure 4‑44: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent |
| Figure 4‑45: Class 2 Device Recall Medtronic Abre |
| Figure 4‑46: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System |
| Figure 4‑47: Class 2 Device Recall ENROUTE Transcarotid Stent System |
| Figure 4‑48: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS |
| Figure 4‑49: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter |
| Figure 4‑50: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter |
| Figure 4‑51: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter |
| Figure 4‑52: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter |
| Figure 4‑53: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter |
| Figure 4‑54: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter |
| Figure 4‑55: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER |
| Figure 4‑56: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter |
| Figure 4‑57: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter |
| Figure 4‑58: Class 2 Device Recall Boston Scientific ROTAPRO |
| Figure 4‑59: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM |
| Figure 4‑60: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM |
| Figure 4‑61: Class 1 Device Recall TurboHawk Plus |
| Figure 4‑62: Class 1 Device Recall HawkOne |
| Figure 4‑63: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System |
| Figure 4‑64: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath |
| Figure 4‑65: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific |
| Figure 4‑66: Class 1 Device Recall IntraClude IntraAortic Occlusion Device |
| Figure 4‑67: Class 2 Device Recall Intergard Woven Vascular Graft |
| Figure 4‑68: Class 2 Device Recall Interavascular SAS/Getinge |
| Figure 4‑69: Class 2 Device Recall Hemashield Gold Knitted Bifurcated |
| Figure 4‑70: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft |
| Figure 4‑71: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts |
| Figure 4‑72: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS |
| Figure 4‑73: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft |
| Figure 4‑74: Class 2 Device Recall VASCUTEK/TERUMO |
| Figure 4‑75: Class 2 Device Recall Gore Propaten Vascular Graft |
| Figure 4‑76: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System |
| Figure 4‑77: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft |
| Figure 4‑78: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System |
| Figure 4‑79: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft |
| Figure 4‑80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft |
| Figure 4‑81: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft |
| Figure 4‑82: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg |
| Figure 4‑83: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft |
| Figure 4‑84: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems |
| Figure 4‑85: Class 2 Device Recall Endurant Stent Graft System |
| Figure 4‑86: Class 2 Device Recall Endurant II Stent Graft System |
| Figure 4‑87: Class 2 Device Recall Endurant II/IIs Stent Graft System |
| Figure 4‑88: Class 2 Device Recall Endurant II/IIs Stent Graft System |
| Figure 4‑89: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System |
| Figure 4‑90: Class 2 Device Recall EKOS |
| Figure 4‑91: Class 2 Device Recall EkoSonic Endovascular Device |
| Figure 4‑92: Class 2 Device Recall EKOS Control System |
| Figure 4‑93: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System |
| Figure 4‑94: Class 1 Device Recall ArrowTrerotola PTD |
| Figure 4‑95: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device |
| Figure 4‑96: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR |
| Figure 4‑97: Class 3 Device Recall Cook |
| Figure 4‑98: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set |
| Figure 4‑99: Class 2 Device Recall ENROUTE Transcarotid Stent System |
| Figure 4‑100: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter |
| Figure 4‑101: Class 2 Device Recall SEEKER(R) Crossing Support Catheter |
| Figure 4‑102: Class 1 Device Recall Imager II 5F Angiographic Catheter |
| Figure 4‑103: Class 1 Device Recall SUPER TORQUE MB 5F PIG |
| Figure 4‑104: Class 1 Device Recall CrossCath Support Catheter |
| Figure 4‑105: Class 2 Device Recall Torcon NB Advantage |
| Figure 4‑106: Class 2 Device Recall Amplatz extra Stiff Wire Guide |
| Figure 4‑107: Class 2 Device Recall Bentson Wire Guide |
| Figure 4‑108: Class 2 Device Recall Cope Mandril Wire Guide |
| Figure 4‑109: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol) |
| Figure 4‑110: Class 2 Device Recall Coons Interventional Wire Guide |
| Figure 4‑111: Class 2 Device Recall Lunderquist Ring Torque Wire Guide |
| Figure 4‑112: Class 2 Device Recall Newton Wire Guide |
| Figure 4‑113: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide |
| Figure 4‑114: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy) |
| Figure 4‑115: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm) |
| Figure 4‑116: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide |
| Figure 4‑117: Class 2 Device Recall Cook Roadrunner PC Wire Guide |
| Figure 4‑118: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide |
| Figure 4‑119: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER |
| Figure 4‑120: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER |
| Figure 4‑121: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER |
| Figure 4‑122: Class 2 Device Recall Avanti Catheter Sheath Introducer |
| Figure 4‑123: Class 2 Device Recall |
| Figure 4‑124: Class 2 Device Recall Flexor CheckFlo Introducer |
| Figure 4‑125: Class 1 Device Recall Flexor CheckFlo Introducer |
| Figure 4‑126: Class 2 Device Recall Hilal Embolization Microcoil |
| Figure 4‑127: Class 2 Device Recall Nester Embolization Microcoil |
| Figure 4‑128: Class 2 Device Recall Tornado Embolization Microcoil |
| Figure 4‑129: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18 |
| Figure 4‑130: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil |
| Figure 4‑131: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil |
| Figure 4‑132: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter |
| Figure 4‑133: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion |
| Figure 4‑134: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM) |
| Figure 4‑135: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE) |
| Figure 4‑136: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (HEAL) |
| Figure 4‑137: SOLARIS Peripheral PMCF Trial |
| Figure 4‑138: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease |
| Figure 4‑139: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY) |
| Figure 4‑140: Stella Supera Siberia |
| Figure 4‑141: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL) |
| Figure 4‑142: Zilver® PTX® V Clinical Study |
| Figure 4‑143: In-Stent Restenosis Post-Approval Study |
| Figure 4‑144: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR) |
| Figure 4‑145: VIVO Clinical Study |
| Figure 4‑146: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease |
| Figure 4‑147: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon |
| Figure 4‑148: Ranger™ and Ranger™ SL (OTW) DCB in China |
| Figure 4‑149: The VaSecure BTK Study |
| Figure 4‑150: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA) |
| Figure 4‑151: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT) |
| Figure 4‑152: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND) |
| Figure 4‑153: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA) |
| Figure 4‑154: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA |
| Figure 4‑155: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease |
| Figure 4‑156: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS) |
| Figure 4‑157: IN.PACT Global Clinical Study |
| Figure 4‑158: ILLUMENATE Pivotal Post-Approval Study (PAS) |
| Figure 4‑159: BIOLUX P-III BENELUX All-Comers Registry |
| Figure 4‑160: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB) |
| Figure 4‑161: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN) |
| Figure 4‑162: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA |
| Figure 4‑163: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Follow-up |
| Figure 4‑164: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I) |
| Figure 4‑165: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon |
| Figure 4‑166: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT) |
| Figure 4‑167: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment |
| Figure 4‑168: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II) |
| Figure 4‑169: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) |
| Figure 4‑170: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System |
| Figure 4‑171: SOLUTION Trial in China |
| Figure 4‑172: Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+) |
| Figure 4‑173: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) |
| Figure 4‑174: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER) |
| Figure 4‑175: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access |
| Figure 4‑176: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study |
| Figure 4‑177: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS) |
| Figure 4‑178: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease |
| Figure 4‑179: Zenith Alpha™ Abdominal Endovascular Graft |
| Figure 4‑180: Fenestrated AAA Endovascular Graft Post-Approval Study |
| Figure 4‑181: transShield Embolic Protection System Feasibility Study |
| Figure 4‑182: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System |
| Figure 4‑183: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER) |
| Figure 4‑184: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (STRIDE) |
| Figure 4‑185: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) |
| Figure 4‑186: JETi Peripheral Thrombectomy Registry (JETi) |
| Figure 4‑187: Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever |
| Figure 4‑188: Forceps vs. Snare IVC Filter Removal |
| Figure 4‑189: Predictors of Attempted Inferior Vena Cava Filters Retrieval |
| Figure 4‑190: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter |
| Figure 4‑191: Cook IVC Filter Study (CIVC) |
| Figure 4‑192: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) |
| Figure 4‑193: Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease |
| Figure 4‑194: The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation (DW-MRI-US) |
| Figure 4‑195: The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Study (DW-MRI OUS) |
| Figure 4‑196: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal) |
| Figure 4‑197: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial |
| Figure 4‑198: Vascular Closure Device in Transcatheter Aortic Valve Replacement |
| Figure 4‑199: Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial (MASH-TAVI) |
| Figure 4‑200: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) |
| Figure 4‑201: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds |
| Figure 4‑202: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs) |
| Figure 4‑203: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization |
| Figure 4‑204: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS) |
| Figure 4‑205: LC Bead LUMI for Prostatic Artery Embolization |
| Figure 5‑1: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (1 of 3) |
| Figure 5‑2: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (2 of 3) |
| Figure 5‑3: Peripheral Vascular Device Market by Segment, U.S., 2019 – 2029 (US$M) (3 of 3) |
| Figure 5‑4: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (1 of 4) |
| Figure 5‑5: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (2 of 4) |
| Figure 5‑6: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (3 of 4) |
| Figure 5‑7: Leading Competitors, Peripheral Vascular Device Market, U.S., 2022 (4 of 4) |
| Figure 5‑8: SWOT Analysis, Abbott (1 of 2) |
| Figure 5‑9: SWOT Analysis, Abbott (2 of 2) |
| Figure 5‑10: SWOT Analysis, Becton Dickinson (1 of 2) |
| Figure 5‑11: SWOT Analysis, Becton Dickinson (2 of 2) |
| Figure 5‑12: SWOT Analysis, Boston Scientific |
| Figure 5‑13: SWOT Analysis, Cardinal Health |
| Figure 5‑14: SWOT Analysis, Cardiovascular Systems, Inc. |
| Figure 5‑15: SWOT Analysis, Cook Medical |
| Figure 5‑16: SWOT Analysis, Medtronic |
| Figure 5‑17: SWOT Analysis, Penumbra |
| Figure 5‑18: SWOT Analysis, Philips |
| Figure 5‑19: SWOT Analysis, Shockwave Medical |
| Figure 5‑20: SWOT Analysis, Silk Road Medical |
| Figure 5‑21: SWOT Analysis, Terumo (1 of 2) |
| Figure 5‑22: SWOT Analysis, Terumo (2 of 2) |
| Figure 5‑23: SWOT Analysis, W.L. Gore |
| Figure 6‑1: Procedure Codes Investigated, U.S., 2022 |
| Figure 6‑2: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (1 of 3) |
| Figure 6‑3: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (2 of 3) |
| Figure 6‑4: Peripheral Vascular Procedures by Segment, U.S., 2019 – 2029 (3 of 3) |
| Figure 6‑5: Above-the-Knee Procedures by Segment, U.S., 2019 – 2029 (1 of 2) |
| Figure 6‑6: Above-the-Knee Procedures by Segment, U.S., 2019 – 2029 (2 of 2) |
| Figure 6‑7: Above-the-Knee Stent Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑8: Above-the-Knee Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑9: Above-the-Knee POBA Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑10: Above-the-Knee DCB Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑11: Intravascular Lithotripsy Procedures, U.S., 2019 – 2029 |
| Figure 6‑12: Above-the-Knee Atherectomy without Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑13: Above-the-Knee Atherectomy with Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑14: Surgical Graft Procedures, U.S., 2019 – 2029 |
| Figure 6‑15: Below-the-Knee Procedures by Intervention Type, U.S., 2019 – 2029 (1 of 2) |
| Figure 6‑16: Below-the-Knee Procedures by Intervention Type, U.S., 2019 – 2029 (2 of 2) |
| Figure 6‑17: Below-the-Knee Stent Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑18: Below-the-Knee Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑19: Below-the-Knee POBA Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑20: Below-the-Knee DCB Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑21: Intravascular Lithotripsy Procedures, U.S., 2019 – 2029 |
| Figure 6‑22: Below-the-Knee Atherectomy without Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑23: Below-the-Knee Atherectomy with Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑24: Surgical Graft Procedures, U.S., 2019 – 2029 |
| Figure 6‑25: Iliac Procedures by Intervention Type, U.S., 2019 – 2029 |
| Figure 6‑26: Iliac Stent Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑27: Iliac Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑28: Iliac POBA Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑29: AV Access Procedures by Intervention Type, U.S., 2019 – 2029 |
| Figure 6‑30: AV Access Covered Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑31: AV Access POBA Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑32: AV Access DCB Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑33: Renal Procedures by Intervention Type, U.S., 2019 – 2029 |
| Figure 6‑34: Carotid Intervention by Procedure Type, U.S., 2019 – 2029 |
| Figure 6‑35: Peripheral Vascular Stent Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑36: Peripheral Arterial Stent Procedures by Stent Type, U.S., 2019 – 2029 |
| Figure 6‑37: Bare-Metal Stent Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑38: Bare-Metal Iliac Stent Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑39: Bare-Metal Fem-Popliteal Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑40: Bare-Metal Infra-Popliteal Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑41: Bare-Metal Stent Procedures by Delivery Method, U.S., 2019 – 2029 |
| Figure 6‑42: Covered Stent Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑43: Drug-Eluting Stent Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑44: Peripheral Venous Stent, U.S., 2019 – 2029 |
| Figure 6‑45: PTA Balloon Catheter Procedures by Segment, U.S., 2019 – 2029 |
| Figure 6‑46: Drug-Coated Balloon Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑47: Drug-Coated Balloon Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑48: Atherectomy Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑49: Atherectomy Procedures by Indication, U.S., 2019 – 2029 (1 of 2) |
| Figure 6‑50: Atherectomy Procedures by Indication, U.S., 2019 – 2029 (2 of 2) |
| Figure 6‑51: Fem-Popliteal Artery Atherectomy Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑52: Infra-Popliteal Artery Atherectomy Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑53: Atherectomy Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 6‑54: Intravascular Lithotripsy Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑55: CTO Device Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑56: Surgical Graft Procedures by Graft Material, U.S., 2019 – 2029 |
| Figure 6‑57: Surgical Graft Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑58: Lower Limb Surgical Graft Procedures by Anatomy, U.S., 2019 – 2029 |
| Figure 6‑59: Aorta Repair Surgical Graft Procedures by Anatomy, U.S., 2019 – 2029 |
| Figure 6‑60: Endovascular Stent Graft Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑61: EVAR Procedures by Anatomy, U.S., 2019 – 2029 |
| Figure 6‑62: EVAR Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑63: EVAR Procedures by Complexity, U.S., 2019 – 2029 |
| Figure 6‑64: EVAR Procedures by Fenestration, U.S., 2019 – 2029 |
| Figure 6‑65: EVAR Procedures by Anesthesia Type, U.S., 2019 – 2029 |
| Figure 6‑66: EVAR Procedures by Gender, U.S., 2019 – 2029 |
| Figure 6‑67: TEVAR Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑68: TEVAR Procedures by Anesthesia Type, U.S., 2019 – 2029 |
| Figure 6‑69: TEVAR Procedures by Gender, U.S., 2019 – 2029 |
| Figure 6‑70: Embolic Protection Procedures by Type, U.S., 2019 – 2029 |
| Figure 6‑71: Peripheral Thrombus Management Procedures by Procedure Type, U.S., 2019 – 2029 |
| Figure 6‑72: Peripheral Thrombus Management Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑73: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2019 – 2029 |
| Figure 6‑74: IVCF Placement Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑75: Carotid Intervention Procedures by Procedure Type, U.S., 2019 – 2029 |
| Figure 6‑76: Vascular Closure Device Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑77: Invasive Vascular Closure Procedures by Device Size, U.S., 2019 – 2029 |
| Figure 6‑78: Vascular Closure Procedures by Approach, U.S., 2019 – 2029 |
| Figure 6‑79: Transcatheter Embolization Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑80: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑81: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2019 – 2029 |
| Figure 6‑82: Peripheral IVUS Procedures by Indication, U.S., 2019 – 2029 |
| Figure 6‑83: Peripheral IVUS Procedures by Care Setting, U.S., 2019 – 2029 |
| Figure 7‑1: Peripheral Vascular Stent Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑2: Peripheral Arterial Stent Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 7‑3: Total Peripheral Arterial Stent Market, U.S., 2019 – 2029 |
| Figure 7‑4: Total Bare-Metal Peripheral Arterial Stent Market, U.S., 2019 – 2029 |
| Figure 7‑5: Bare-Metal Peripheral Arterial Stent Market by Indication, U.S., 2019 – 2029 |
| Figure 7‑6: Bare-Metal Carotid Stent Market, U.S., 2019 – 2029 |
| Figure 7‑7: Bare-Metal Iliac Stent Market, U.S., 2019 – 2029 |
| Figure 7‑8: Bare-Metal Renal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑9: Bare-Metal Fem-Popliteal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑10: Bare-Metal Infra-Popliteal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑11: Bare-Metal Stent Market by Delivery Platform, U.S., 2019 – 2029 |
| Figure 7‑12: Self-Expanding Bare-Metal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑13: Balloon Expanding Bare-Metal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑14: Covered Stent Market by Segment, U.S., 2019 – 2029 |
| Figure 7‑15: Total Covered Stent Market, U.S., 2019 – 2029 |
| Figure 7‑16: Iliac Covered Stent Market, U.S., 2019 – 2029 |
| Figure 7‑17: Fem-Popliteal Covered Stent Market, U.S., 2019 – 2029 |
| Figure 7‑18: AV Access Covered Stent Market, U.S., 2019 – 2029 |
| Figure 7‑19: Drug-Eluting Stent Market by Segment, U.S., 2019 – 2029 |
| Figure 7‑20: Total Drug-Eluting Stent Market, U.S., 2019 – 2029 |
| Figure 7‑21: SFA Drug-Eluting Stent Market, U.S., 2019 – 2029 |
| Figure 7‑22: Infra-Popliteal Drug-Eluting Stent Market, U.S., 2019 – 2029 |
| Figure 7‑23: Venous Stent Market, U.S., 2019 – 2029 |
| Figure 7‑24: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, U.S., 2019 – 2029 |
| Figure 7‑25: Units Sold by Stent Length, Bare-Metal Renal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑26: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, U.S., 2019 – 2029 |
| Figure 7‑27: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, U.S., 2019 – 2029 |
| Figure 7‑28: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2022 |
| Figure 7‑29: Leading Competitors, Bare-Metal Arterial Peripheral Vascular Stent Market, U.S., 2022 |
| Figure 7‑30: Leading Competitors, Drug-Eluting Peripheral Vascular Stent Market, U.S., 2022 |
| Figure 8‑1: PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑2: Total PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑3: Standard PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑4: Total Standard PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑5: Hospital Standard PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑6: Office-Based Lab Standard PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑7: High-Pressure PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑8: Total High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑9: Hospital High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑10: Office-Based Lab High-Pressure PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑11: Large PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑12: Total Large PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑13: Hospital Large PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑14: Office-Based Lab Large PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑15: Total Small PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑16: 0.014” Small PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑17: 0.018” Small PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑18: Hospital Small PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑19: Office-Based Lab Small PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑20: Specialty PTA Balloon Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 8‑21: Total Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑22: Hospital Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑23: Office-Based Lab Specialty PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑24: Units Sold by Application, PTA Balloon Catheter Market, U.S., 2019 – 2029 |
| Figure 8‑25: Leading Competitors, PTA Balloon Catheter Market, U.S., 2022 |
| Figure 9‑1: Drug-Coated Balloon Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 9‑2: Total Drug-Coated Balloon Market, U.S., 2019 – 2029 |
| Figure 9‑3: SFA DCB Market, U.S., 2019 – 2029 |
| Figure 9‑4: BTK DCB Market, U.S., 2019 – 2029 |
| Figure 9‑5: AV Access DCB Market, U.S., 2019 – 2029 |
| Figure 9‑6: Units Sold by Care Setting, Drug-Coated Balloon Market, U.S., 2019 – 2029 |
| Figure 9‑7: Leading Competitors, Drug-Coated Balloon Market, U.S., 2022 |
| Figure 10‑1: Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 10‑2: Total Laser Atherectomy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 10‑3: Laser Atherectomy Disposable Market, U.S., 2019 – 2029 |
| Figure 10‑4: Laser Atherectomy Console Market, U.S., 2019 – 2029 (1 of 2) |
| Figure 10‑5: Laser Atherectomy Console Market, U.S., 2019 – 2029 (2 of 2) |
| Figure 10‑6: Mechanical Atherectomy Disposable Market, U.S., 2019 – 2029 |
| Figure 10‑7: Atherectomy Disposable Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 10‑8: Hospital Atherectomy Disposable Market, U.S., 2019 – 2029 |
| Figure 10‑9: Office-Based Lab Atherectomy Disposable Market, U.S., 2019 – 2029 |
| Figure 10‑10: Leading Competitors, Atherectomy Device Market, U.S., 2022 |
| Figure 11‑1: Intravascular Lithotripsy Market by Care Setting, U.S., 2019 – 2029 (US$M) |
| Figure 11‑2: Hospital Intravascular Lithotripsy Market, U.S., 2019 – 2029 |
| Figure 11‑3: Office-Based Lab Intravascular Lithotripsy Market, U.S., 2019 – 2029 |
| Figure 11‑4: Leading Competitors, Intravascular Lithotripsy Market, U.S., 2022 |
| Figure 12‑1: CTO Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 12‑2: Total CTO Device Market, U.S., 2019 – 2029 |
| Figure 12‑3: Re-Entry Device Market, U.S., 2019 – 2029 |
| Figure 12‑4: Re-Canalization Device Market, U.S., 2019 – 2029 |
| Figure 12‑5: Leading Competitors, CTO Device Market, U.S., 2022 |
| Figure 13‑1: Surgical Graft Market by Indication, U.S., 2019 – 2029 (US$M) |
| Figure 13‑2: Surgical Graft Market by Material, U.S., 2019 – 2029 (US$M) |
| Figure 13‑3: Total Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑4: Lower Limb Surgical Graft Market, U.S., 2019 – 2029 (US$M) |
| Figure 13‑5: Total Lower Limb Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑6: Above-the-Knee Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑7: Below-the-Knee Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑8: Aorta Repair Surgical Graft Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 13‑9: Total Aorta Repair Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑10: Abdominal Aortic Aneurysm Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑11: Thoracic Aortic Aneurysm Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑12: Extra-Anatomical Bypass Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑13: Polyester Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑14: ePTFE Surgical Graft Market, U.S., 2019 – 2029 |
| Figure 13‑15: Leading Competitors, Surgical Graft Market, U.S., 2022 |
| Figure 14‑1: Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑2: Total Stent Graft Market, U.S., 2019 – 2029 |
| Figure 14‑3: AAA Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑4: Total AAA Stent Graft Market, U.S., 2019 – 2029 |
| Figure 14‑5: Bifurcated Main Body Graft Market, U.S., 2019 – 2029 |
| Figure 14‑6: Contralateral/Ipsilateral Iliac Leg/Limb Market, U.S., 2019 – 2029 |
| Figure 14‑7: Aorto-uni-iliac (AUI) Stent Graft Market, U.S., 2019 – 2029 |
| Figure 14‑8: Iliac Extension Market, U.S., 2019 – 2029 |
| Figure 14‑9: Aortic Extension Market, U.S., 2019 – 2029 |
| Figure 14‑10: FAA Stent Graft Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 14‑11: Total FAA Stent Graft Market, U.S., 2019 – 2029 |
| Figure 14‑12: Fenestrated Distal Bifurcated Graft Market, U.S., 2019 – 2029 |
| Figure 14‑13: Fenestrated Proximal Body Graft Market, U.S., 2019 – 2029 |
| Figure 14‑14: TAA Stent Graft Market, U.S., 2019 – 2029 |
| Figure 14‑15: Leading Competitors, Stent Graft Market, U.S., 2022 |
| Figure 14‑16: Leading Competitors, AAA Stent Graft Market, U.S., 2022 |
| Figure 15‑1: Embolic Protection Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 15‑2: Total Embolic Protection Device Market, U.S., 2019 – 2029 |
| Figure 15‑3: Carotid EPD Market, U.S., 2019 – 2029 |
| Figure 15‑4: Alternative EPD Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 15‑5: Total Alternative EPD Market, U.S., 2019 – 2029 |
| Figure 15‑6: Renal EPD Market, U.S., 2019 – 2029 |
| Figure 15‑7: Lower Limb EPD Market, U.S., 2019 – 2029 |
| Figure 15‑8: Leading Competitors, Embolic Protection Device Market, U.S., 2022 |
| Figure 16‑1: Peripheral Thrombus Management Market Overview by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 16‑2: Peripheral Thrombus Management Market Overview by Indication, U.S., 2019 – 2029 (US$M) |
| Figure 16‑3: Total Peripheral Thrombus Management Market, U.S., 2019 – 2029 |
| Figure 16‑4: Traditional Thrombectomy Market, U.S., 2019 – 2029 |
| Figure 16‑5: Pharmacomechanical Thrombectomy Market, U.S., 2019 – 2029 |
| Figure 16‑6: Catheter Directed Thrombolysis Market, U.S., 2019 – 2029 |
| Figure 16‑7: AV Access Thrombectomy Device Market, U.S., 2019 – 2029 |
| Figure 16‑8: Arterial Thrombectomy Device Market, U.S., 2019 – 2029 |
| Figure 16‑9: Venous Thrombectomy Device Market, U.S., 2019 – 2029 |
| Figure 16‑10: Leading Competitors, Peripheral Thrombus Management Market, U.S., 2022 |
| Figure 17‑1: Inferior Vena Cava Filter & Retrieval Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 17‑2: Retrievable IVCF Market, U.S., 2019 – 2029 |
| Figure 17‑3: Permanent IVCF Market, U.S., 2019 – 2029 |
| Figure 17‑4: IVCF Retrieval Device Market, U.S., 2019 – 2029 |
| Figure 17‑5: Leading Competitors, Inferior Vena Cava Filter & Retrieval Device Market, U.S., 2022 |
| Figure 18‑1: Carotid Shunt Market, U.S., 2019 – 2029 |
| Figure 18‑2: Leading Competitors, Carotid Shunt Market, U.S., 2022 |
| Figure 19‑1: Transcarotid Artery Revascularization Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 19‑2: Transcarotid Bare-Metal Stent Market, U.S., 2019 – 2029 |
| Figure 19‑3: TCAR Neuroprotection System Market, U.S., 2019 – 2029 |
| Figure 19‑4: Leading Competitors, Transcarotid Artery Revascularization Market, U.S., 2022 |
| Figure 20‑1: Diagnostic & Interventional Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 20‑2: Total Diagnostic & Interventional Catheter Market, U.S., 2019 – 2029 |
| Figure 20‑3: Diagnostic Catheter Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 20‑4: Total Diagnostic Catheter Market, U.S., 2019 – 2029 |
| Figure 20‑5: Standard Diagnostic Catheter Market, U.S., 2019 – 2029 |
| Figure 20‑6: Hydrophilic Diagnostic Catheter Market, U.S., 2019 – 2029 |
| Figure 20‑7: Support Catheter Market, U.S., 2019 – 2029 |
| Figure 20‑8: Leading Competitors, Diagnostic & Interventional Catheter Market, U.S., 2022 |
| Figure 21‑1: Diagnostic & Interventional Guidewire Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 21‑2: Total Diagnostic & Interventional Guidewire Market, U.S., 2019 – 2029 |
| Figure 21‑3: Standard Guidewire Market, U.S., 2019 – 2029 |
| Figure 21‑4: Hydrophilic Guidewire Market, U.S., 2019 – 2029 |
| Figure 21‑5: Leading Competitors, Diagnostic & Interventional Guidewire Market, U.S., 2022 |
| Figure 22‑1: Introducer Sheath Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 22‑2: Total Introducer Sheath Market, U.S., 2019 – 2029 |
| Figure 22‑3: Standard Introducer Sheath Market, U.S., 2019 – 2029 |
| Figure 22‑4: Guiding Introducer Sheath Market, U.S., 2019 – 2029 |
| Figure 22‑5: Leading Competitors, Introducer Sheath Market, U.S., 2022 |
| Figure 23‑1: Vascular Closure Device Market by Device Type, U.S., 2019 – 2029 (US$M) |
| Figure 23‑2: Vascular Closure Device Market by Approach, U.S., 2019 – 2029 (US$M) |
| Figure 23‑3: Total Vascular Closure Device Market, U.S., 2019 – 2029 |
| Figure 23‑4: Non-Invasive VCD Market, U.S., 2019 – 2029 |
| Figure 23‑5: Invasive Vascular Closure Device Market by Application, U.S., 2019 – 2029 (US$M) |
| Figure 23‑6: Total Invasive Vascular Closure Device Market, U.S., 2019 – 2029 |
| Figure 23‑7: Small-Bore Invasive VCD Market, U.S., 2019 – 2029 |
| Figure 23‑8: Large-Bore Invasive VCD Market, U.S., 2019 – 2029 |
| Figure 23‑9: Radial VCD Market, U.S., 2019 – 2029 |
| Figure 23‑10: Femoral VCD Market, U.S., 2019 – 2029 |
| Figure 23‑11: Leading Competitors by Device Type, Vascular Closure Device Market, U.S., 2022 |
| Figure 23‑12: Leading Competitors, Invasive Vascular Closure Device Market, U.S., 2022 |
| Figure 23‑13: Leading Competitors by Approach, Vascular Closure Device Market, U.S., 2022 |
| Figure 24‑1: Transcatheter Embolization Device Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 24‑2: Total Transcatheter Embolization Device Market, U.S., 2019 – 2029 |
| Figure 24‑3: Embolization Particle Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 24‑4: Total Embolization Particle Market, U.S., 2019 – 2029 |
| Figure 24‑5: PVA Embolization Particle Market, U.S., 2019 – 2029 |
| Figure 24‑6: Microsphere Embolization Particle Market, U.S., 2019 – 2029 |
| Figure 24‑7: Drug-Eluting Embolization Particle Market, U.S., 2019 – 2029 |
| Figure 24‑8: Radioactive Embolization Particle Market, U.S., 2019 – 2029 |
| Figure 24‑9: Embolization Coil Market by Segment, U.S., 2019 – 2029 (US$M) |
| Figure 24‑10: Total Embolization Coil Market, U.S., 2019 – 2029 |
| Figure 24‑11: Pushable Coil Market, U.S., 2019 – 2029 |
| Figure 24‑12: Detachable Coil Market, U.S., 2019 – 2029 |
| Figure 24‑13: Embolization Liquid Market, U.S., 2019 – 2029 |
| Figure 24‑14: Embolization Plug Market, U.S., 2019 – 2029 |
| Figure 24‑15: Leading Competitors, Transcatheter Embolization Device Market, U.S., 2022 |
| Figure 24‑16: Leading Competitors, Embolization Particle Market, U.S., 2022 |
| Figure 24‑17: Leading Competitors, Embolization Coil Market, U.S., 2022 |
| Figure 25‑1: Peripheral IVUS Catheter Market, U.S., 2019 – 2029 |
| Figure 25‑2: Leading Competitors, Peripheral IVUS Catheter Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Peripheral Vascular Devices Market Size, Share & Trends Analysis | United States | 2023-2029 | MedSuite | Includes: Peripheral Vascular Stents, PTA Balloon Catheters, and 17 more
$7,995 – $9,995
The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.
- 2023
- 10 Years
- United States
- 2023-02-14
- 756
- MedSuite
Related Reports
